Lyons R F, Rumore M M, Merola M R
Arnold & Marie Schwartz College of Pharmacy, Long Island University, Brooklyn, NY 11201, USA.
J Clin Pharm Ther. 1996 Aug;21(4):221-8. doi: 10.1111/j.1365-2710.1996.tb01142.x.
The need for patient package inserts (PPI) has been a controversial issue for many years. In August 1995, the FDA proposed 'MedGuide', a mandatory PPI programme. Recent efforts to educate patients about drug therapy include the OBRA '90 (Omnibus Budget Reconciliation Act of 1990) requirement for pharmacists to offer counselling to all patients receiving prescription drugs. In order to assess if patient information needs are being met, an 18-item survey was distributed to 873 patients at eight randomly selected New Jersey pharmacies until 100 patients had anonymously responded. Seventy-five per cent or more of respondents indicated that they received the following information from a health professional: medication name, reason prescribed, how often to take and duration of therapy. Less than 50% of respondents received information concerning: storage conditions, over-the-counter (OTC) or prescription only (Rx) interactions, what happens to the body if a dose is missed and how to avoid side-effects. Using a five item scale, every item was rated as important by at least 60% of respondents. Although information was reaching the majority of patients who responded, there were still some gaps between that which they considered to be important and information actually received. Some additional intervention might be beneficial to help to bridge these informational gaps.
多年来，患者用药指导手册（PPI）的必要性一直是个有争议的问题。1995年8月，美国食品药品监督管理局（FDA）提出了“药物指南”这一强制性PPI项目。近期为患者提供药物治疗教育的举措包括1990年综合预算协调法案（OBRA '90）要求药剂师为所有接受处方药治疗的患者提供咨询服务。为了评估患者的信息需求是否得到满足，一项包含18个条目的调查问卷被分发给新泽西州随机挑选的8家药店的873名患者，直至收到100名患者的匿名回复。75%或更多的受访者表示他们从医疗专业人员那里获得了以下信息：药物名称、开药原因、服药频率和治疗时长。不到50%的受访者收到了以下方面的信息：储存条件、非处方药（OTC）或仅处方药（Rx）的相互作用、漏服一剂药后身体会出现什么情况以及如何避免副作用。使用五分制量表，每个条目至少60%的受访者都认为很重要。尽管信息传达给了大多数回复的患者，但他们认为重要的信息与实际收到的信息之间仍存在一些差距。一些额外的干预措施可能有助于弥补这些信息差距。
